TAF is an investigational treatment (Gilead Sciences) for CHB while TDF is an approved treatment option and is one of the two guideline-recommended nu...
Not all breast cancer relapse after treatment, but why some relapse while some do not? A group of cancer researchers from Wellcome Trust Sanger Instit...
There might be niche for specific bevacizumab-containing regimen with more favourable survival (OS) advantage in locally recurrent/ metastatic breast ...
Chronic constipation (CC) is associated with a number of serious gastrointestinal (GI) disorders, including colorectal cancer (CRC), gastric cancer an...
For the first time with clear and positive evidence, women with early breast cancer treated with accelerated partial-breast irradiation (APBI) did equ...
Being diagnosed with breast cancer is already devastating for young women. If frontline chemotherapy could possibly push their ovaries into failure an...
AZD9291 (or osimertinib), an investigational third generation tyrosine kinase inhibitor, demonstrated 60%+ and 75% objective response rates (ORR: comp...
Atezolizumab (Genetech/ Roche), another immunotherapy, is found effective in extending survival with favourable tolerability in selected patients with...
The use of statins is associated with >40% lower risk of decompensation and death in HCV infected patients with compensated cirrhosis, according to...
